Re: Comparison of immediate vs. deferred cytoreductive nephrectomy in patients with synchronous metastatic renal cell carcinoma receiving sunitinib: the SURTIME randomized clinical trial

被引：1
|
作者：
Minervini, Andrea [1 ]
Mari, Andrea [1 ]
Di Maida, Fabrizio [1 ]
Campi, Riccardo [1 ]
Carini, Marco [1 ]
Lapini, Alberto [1 ]
机构：
[1] Univ Florence, Careggi Hosp, Unit Oncol Minimally Invas Urol & Androl, Dept Urol, Florence, Italy
来源：
TRANSLATIONAL CANCER RESEARCH | 2019年 / 8卷
关键词：
INTERFERON-ALPHA; MONOTHERAPY; CANCER;
D O I：
10.21037/tcr.2019.03.08
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：S208 / S210
页数：3
相关论文
共 50 条
  • [41] Upfront (uCN) vs. deferred (dCN) cytoreductive nephrectomy (CN) in metastatic renal cell carcinoma (mRCC): A systematic review and individual patient data (IPD) meta-analysis of 3323 patients
    Esagian, Stepan M.
    Karam, Jose A.
    Msaouel, Pavlos
    Makrakis, Dimitrios
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (4_SUPPL) : 440 - 440
  • [42] Sunitinib in patients with or without prior nephrectomy (Nx) in an expanded access trial of metastatic renal cell carcinoma (mRCC)
    Szczylik, C.
    Porta, C.
    Bracarda, S.
    Hawkins, R.
    Bjarnason, G. A.
    Oudard, S.
    Lee, S.
    Carteni, G.
    Hariharan, S.
    Gore, M. E.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [43] Cytoreductive nephrectomy (CN) in patients with synchronous metastases from renal cell carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC)
    Heng, Daniel Yick Chin
    Rini, Brian I.
    Beuselinck, Benoit
    Lee, Jae-Lyun
    Knox, Jennifer J.
    Bjarnason, Georg A.
    Pal, Sumanta Kumar
    Kollmannsberger, Christian K.
    Yuasa, Takeshi
    Srinivas, Sandy
    Donskov, Frede
    Bamias, Aristotelis
    Wood, Lori
    Ernst, D. Scott
    Agarwal, Neeraj
    Vaishampayan, Ulka N.
    Rha, Sun Young
    Kim, Jenny J.
    Kanesvaran, Ravindran
    Choueiri, Toni K.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (04)
  • [44] Using presurgical sunitinib to select patients with newly diagnosed metastatic clear cell renal cell carcinoma for cytoreductive nephrectomy: A phase II study
    Jonasch, Eric
    Wood, Christopher G.
    Corn, Paul G.
    Sharma, Padmanee
    Pagliaro, Lance C.
    Aparicio, Ana
    Do, Kim-Anh
    Wang, Xuemei
    Marcott, Valerie D.
    Matin, Surena F.
    Tannir, Nizar M.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (06)
  • [45] Impact of Prior Cytoreductive Nephrectomy on Efficacy in Patients with Synchronous Metastatic Renal Cell Carcinoma Treated with Avelumab plus Axitinib or Sunitinib: Post Hoc Analysis from the JAVELIN Renal 101 Phase 3 Trial.
    Froehner, Michael
    EUROPEAN UROLOGY, 2024, 86 (05)
  • [46] A COMPARISON OF OPEN RADICAL NEPHRECTOMY COMPLICATION RATES IN PATIENTS TREATED WITH NEOADJUVANT SUNITINIB FOR METASTATIC RENAL CELL CARCINOMA VERSUS NON-METASTATIC RENAL CELL CARCINOMA
    Hussain, M.
    Nair, R.
    Bycroft, J.
    Green, J. S. A.
    Powles, T.
    Peters, J. L.
    EUROPEAN UROLOGY SUPPLEMENTS, 2011, 10 (02) : 103 - 103
  • [47] Prognostic relevance of sunitinib toxicities and comparison of continuous vs. intermittent sunitinib dosing schedule in metastatic renal cell cancer patients
    Ordu, Cetin
    Pilanci, Kezban N.
    Avci, Nilufer
    Yildiz, Ibrahim
    Alco, Gul
    Demirhan, Ozkan
    Koksal, Ulkuhan I.
    Elbuken, Filiz
    Tecimer, Coskun
    Demir, Gokhan
    WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, 2016, 20 (02): : 147 - 152
  • [48] The Impact of Cytoreductive Nephrectomy on Survival of Patients With Metastatic Renal Cell Carcinoma Receiving Vascular Endothelial Growth Factor Targeted Therapy
    Choueiri, Toni K.
    Xie, Wanling
    Kollmannsberger, Christian
    North, Scott
    Knox, Jennifer J.
    Lampard, J. Geoffrey
    McDermott, David F.
    Rini, Brian I.
    Heng, Daniel Y. C.
    JOURNAL OF UROLOGY, 2011, 185 (01): : 60 - 66
  • [49] Differences in survival of clear cell metastatic renal cell carcinoma patients according to partial vs. radical nephrectomy
    Garcia, Cano C.
    Flammia, R. S.
    Piccinelli, M.
    Panunzio, A.
    Tappero, S.
    Barletta, F.
    Incesu, R-B
    Law, K.
    Tian, Z.
    Saad, F.
    Kapoor, A.
    Shariat, S. F.
    Tilki, D.
    Briganti, A.
    Terrone, C.
    Antonelli, A.
    De Cobelli, O.
    Hoeh, B.
    Kluth, L. A.
    Chun, F. K. H.
    Karakiewicz, P., I
    EUROPEAN UROLOGY, 2023, 83 : S477 - S478
  • [50] Position of cytoreductive nephrectomy in the setting of metastatic renal cell carcinoma patients: does the CARMENA trial lead to a paradigm shift?
    Dariane, Charles
    Timsit, Marc-Olivier
    Mejean, Arnaud
    BULLETIN DU CANCER, 2018, 105 : S229 - S234
12345